China's CanSino to offer tens of millions of COVID-19 vaccines to COVAX
BEIJING - China's CanSino Biologics Inc has proposed providing "tens of million of doses" of its single-dose COVID-19 vaccine to global vaccine sharing scheme COVAX, Reuters quoted a senior executive of the company as saying.
Pierre Morgon, senior vice president at CanSino, told the media outlet in an interview that the firm made the proposal in December last year to supply vaccines between late 2021 and the end of 2022.
"We are happy to go beyond 2022 if there was still an expectation to do so," Morgon was quoted in the report on Thursday.
The offering to COVAX, which is backed by the World Health Organization, is the lowest price that CanSino uses in markets outside China, where richer countries are subject to prices about three times higher, the report added.
- Interest in Turkiye soars among Chinese tourists after introduction of visa-free entry
- Yunnan e-bike fire probe identifies raft of failings
- Investigation report released on e-bike fire that killed 8 in Southwest China
- Understanding Xi's vision of China and the world through New Year message
- 'Artificial sun' experiment finds way to break plasma density limit
- China reports 20% rise in inter-regional trips on first day of holiday
